Abstract | BACKGROUND: METHODS: We used a retrospective bioinformatics analysis to identify neurosurgical inpatients who had undergone a protocol assessing the serum D-dimer levels and had undergone a VDU study to evaluate for the presence of VTE from March 2008 through July 2017. The clinical risk factors and D-dimer levels were evaluated for the prediction of VTE. RESULTS: In the 1918 patient encounters identified, the overall VTE detection rate was 28.7%. Using a receiver operating characteristic curve, an area under the curve of 0.58 was identified for all D-dimer values (P = 0.0001). A D-dimer level of ≥2.5 μg/mL on admission conferred a 30% greater relative risk of VTE (sensitivity, 0.43; specificity, 0.67; positive predictive value, 0.27; negative predictive value, 0.8). A D-dimer value of ≥3.5 μg/mL during hospitalization yielded a 28% greater relative risk of VTE (sensitivity, 0.73; specificity, 0.32; positive predictive value, 0.24; negative predictive value, 0.81). Multivariable logistic regression showed that age, male sex, length of stay, tumor or other neurological disease diagnosis, and D-dimer level ≥3.5 μg/mL during hospitalization were independent predictors of VTE. CONCLUSIONS: The D-dimer protocol was beneficial in identifying VTE in a heterogeneous group of neurosurgical patients by prompting VDU evaluation for patients with a D-dimer values of ≥3.5 μg/mL during hospitalization. Refinement of this screening model is necessary to improve the identification of VTE in a practical and cost-effective manner.
|
Authors | Michael Karsy, Mohammed A Azab, Jonathan Harper, Hussam Abou-Al-Shaar, Jian Guan, Ilyas Eli, Andrea A Brock, Ryan D Ormond, Patrick W Hosokawa, Ramkiran Gouripeddi, Ryan Butcher, Chad D Cole, Sarah T Menacho, William T Couldwell |
Journal | World neurosurgery
(World Neurosurg)
Vol. 133
Pg. e774-e783
(Jan 2020)
ISSN: 1878-8769 [Electronic] United States |
PMID | 31605841
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Fibrin Fibrinogen Degradation Products
- fibrin fragment D
|
Topics |
- Adult
- Aged
- Biomarkers
(blood)
- Female
- Fibrin Fibrinogen Degradation Products
(analysis)
- Humans
- Male
- Middle Aged
- Retrospective Studies
- Sensitivity and Specificity
- Venous Thromboembolism
(blood, diagnosis)
- Venous Thrombosis
(blood)
|